作为hCA IX抑制剂的triazinyl-benzenesulfonamide衍生物:使用优化的停止流方法设计,合成和活性确定
Vojtech Varecka1, Karolina Seligova2, Alena Hofrova3
1Department of Chemistry, Faculty of Science, Masaryk University, Kotlarska 2, 611 37 Brno, Czech Republic.
Bioorganic chemistry
|January 27, 2026
概括
研究人员开发了新的1,3,5-triazinyl-benzenesulfonamide衍生物,作为人类碳酸无水酶IX (CA IX) 的强有力的抑制剂. 这些化合物对与癌症相关的CA IX具有有前途的选择性和活性,表现优于乙胺.
科学领域:
- 药用化学 医学化学
- 生物化学 生物化学
- 药物发现 药物发现 药物发现
背景情况:
- 人类碳酸无水酶 (HCA) 是参与各种生理过程的关键酶.
- CA IX是经过验证的与癌症相关的标,这使其成为抗癌药物开发的重点.
- 选择性抑制CA IX与其他异构体 (如CA II) 相比,对于治疗疗效和最小化副作用至关重要.
研究的目的:
- 设计,合成和评估一系列新的1,3,5-triazinyl二硫胺衍生物.
- 在潜在的抗癌应用中实现选择性抑制人类碳酸无水酶IX (CA IX).
- 建立结构-活性关系 (SAR),指导强效和选择性CA IX抑制剂的开发.
主要方法:
- 新型1,3,5-triazinyl二硫胺衍生物的合成,包括多种不同的部分.
- 分子对接研究,以预测对CA IX的结合亲和性和选择性.
- 使用停止流光谱仪对HCA II和CA IX的抑制活性进行体外生物评估.
- 抑制常数 (KI) 和选择性比率的确定.
主要成果:
- 几种合成的化合物显示出对CA IX的显著抑制活性.
- 化合物9和38表现出强烈的抑制 (KI = 7.4 nM和9.4 nM,分别) 和选择性超过临床基准乙胺.
- 结构-活性关系分析表明,结构刚性和疏水性与增强的抑制活性和选择性相关.
- 一种更新的止流光谱光度测量方法促进了高通量和精确的KI确定.
结论:
- 新的1,3,5-triazinyl二硫胺衍生物代表了一类有前途的选择性CA IX抑制剂.
- 化合物9和38是作为针对CA IX的抗癌剂进一步开发的首选候选物质.
- 这项研究为选择性CA IX抑制的结构要求提供了宝贵的见解.
- 描述的方法提高了酶抑制常数的确定精度和效率.
相关概念视频
Design Example: Flow Through a Fire Extinguisher
466
A fire extinguisher that uses pressurized water relies on fluid dynamics principles to generate a high-velocity stream capable of suppressing flames. The water is stored at a much higher pressure inside the extinguisher than the surrounding atmosphere. This pressure difference forces the water to flow rapidly when the extinguisher is activated, and the behavior of the water as it exits the nozzle can be understood using fundamental equations of fluid dynamics.
The key to understanding how the...
The key to understanding how the...
466
Eukaryotic Transcription Inhibitors
11.0K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.0K
Design Example: Flow of Oil Through Circular Pipes
461
Understanding fluid flow behavior through pipes is critical in fluid mechanics, especially in applications like oil transportation through pipelines. Hagen-Poiseuille's law provides an exact solution derived from the Navier-Stokes equations for steady, incompressible, and laminar flow within a circular pipe. Hagen-Poiseuille's law helps determine the necessary pressure drop across a pipeline section by determining parameters like pipe length, radius, oil viscosity, and the desired volumetric...
461
Factorial Design
13.8K
Factorial Analysis is an experimental design that applies Analysis of Variance (ANOVA) statistical procedures to examine a change in a dependent variable due to more than one independent variable, also known as factors. Changes in worker productivity can be reasoned, for example, to be influenced by salary and other conditions, such as skill level. One way to test this hypothesis is by categorizing salary into three levels (low, moderate, and high) and skills sets into two levels (entry level...
13.8K
Structure-Activity Relationships and Drug Design
1.8K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.8K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.2K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.2K


